Haemonetics Corp. (HAE)

Haemonetics (HAE) Financial Statements


Haemonetics Financial Overview

Haemonetics's market cap is currently ―. The company's EPS TTM is $2.287; its P/E ratio is 38.79; Haemonetics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $1.00. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Apr 23
Income Statement-
Total Revenue$ 343.29M$ 336.25M$ 318.18M$ 311.33M-
Gross Profit$ 175.91M$ 177.87M$ 170.51M$ 167.26M-
EBIT$ 23.18M$ 44.03M$ 32.83M$ 51.59M-
EBITDA$ 54.95M$ 68.34M$ 56.63M$ 75.45M-
Net Income Common Stockholders$ 20.37M$ 31.24M$ 39.40M$ 41.04M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 178.80M$ 193.98M$ 351.00M$ 285.72M$ 284.47M
Total Assets$ 2.20B$ 2.20B$ 2.01B$ 1.96B$ 1.93B
Total Debt$ 807.79M$ 870.59M$ 762.23M$ 764.95M$ 765.89M
Net Debt$ 628.99M$ 676.61M$ 411.22M$ 479.23M$ 481.42M
Total Liabilities$ 1.24B$ 1.26B$ 1.12B$ 1.10B$ 1.12B
Stockholders Equity$ 959.96M$ 943.32M$ 893.66M$ 864.62M$ 818.00M
Cash Flow-
Free Cash Flow$ 54.95M$ -22.50M$ 72.12M$ 12.70M$ 66.49M
Operating Cash Flow$ 64.08M$ -540.00K$ 96.25M$ 21.96M$ 84.49M
Investing Cash Flow$ -13.06M$ -268.94M$ -25.14M$ -15.26M$ -18.51M
Financing Cash Flow$ -63.50M$ 109.43M$ -4.30M$ -3.47M$ -5.98M
Currency in USD

Haemonetics Earnings and Revenue History

Haemonetics Debt to Assets

Haemonetics Cash Flow

Haemonetics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis